Litigation Summary and Analysis for SALIX PHARMACEUTICALS, INC. v. CIPLA USA, INC. Introduction The litigation between Salix Pharmaceuticals, Inc. and […]
SALIX PHARMACEUTICALS, INC. v. CIPLA USA, INC. Read Post »
The pharmaceutical industry has undergone significant transformations, driven by the need for rapid innovation and adaptation. Contract Development and Manufacturing
How CDMOs are Transforming the Pharmaceutical Industry Read Post »
DEFENCATH (heparin sodium; taurolidine) Cormedix Patent: 9,339,036 Expiration: Nov 2, 2024 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of October 27, 2024 Read Post »
The pharmaceutical industry is known for its complex regulatory environment and lengthy product development processes. One often overlooked aspect of
Unlocking the Potential of Abandoned and Expired Patents Read Post »
In the rapidly evolving landscape of biotechnology and pharmaceutical development, contract development and manufacturing organizations (CDMOs) have become essential partners
Unlocking the Full Potential of Your CDMO Partnership: Strategies for Success Read Post »
The pharmaceutical industry relies heavily on Contract Development and Manufacturing Organizations (CDMOs) to streamline the drug development and manufacturing process.
Top 10 CDMO Services You Didn’t Know You Needed Read Post »
A troubling trend has emerged in recent years, leaving both healthcare providers and patients grappling with an unexpected challenge: the
The Persistent Problem: Why Hospitals Keep Running Out of Generic Drugs Read Post »
The generic drug industry faces significant regulatory challenges that can impact the quality and safety of these life-saving medications. With
How to Manage Regulatory Challenges in Generic Drugs Read Post »
The pharmaceutical industry has faced significant challenges in recent years, including the loss of patents, increased regulatory scrutiny, and rising
Prioritizing Patient Centricity in Generic Drug Development Read Post »
Get fresh news and insights, drug patent expirations & more…
